NTLA
USDIntellia Therapeutics Inc. Common Stock
$12.200-0.400 (-3.175%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$12.600
High
$13.110
Low
$12.190
Volume
3.02M
Company Fundamentals
Market Cap
1.3B
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
7.14M
Exchange
NGM
Currency
USD
52-Week Range
Low $5.9Current $12.200High $28.25
Related News
Analyst Upgrades
HC Wainwright & Co. Maintains Buy on Intellia Therapeutics, Lowers Price Target to $18
HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Intellia Therapeutics with a Buy and lowers the price target from $25 to $18.
View more
Related Stocks
FMY
First Trust Motgage Income Fund Common Shares of Beneficial Interest
NASDAQ
Finance/Investo...
GNTX
Gentex Corporation
NASDAQ
Auto Parts:O.E....
ADV
Advantage Solutions Inc.
NASDAQ
Business Servic...
EOI
Eaton Vance Enhance Equity Income Fund Eaton Vance Enhanced Equity Income Fund Shares of Beneficial Interest
NASDAQ
Finance/Investo...
ROAD
Construction Partners Inc.
NASDAQ
Military/Govern...
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.